The aim of this work was to investigate the effects of Aloe vera leaf pulp and gel extracts on the liver tissue of neonatal streptozotocin (n0STZ)-induced type-II diabetic rats. The diabetic rats were separated into four groups and each group was given the following samples by gavage, daily for 15 d: phosphate buffered saline (PBS; diabetic control), Aloe leaf pulp extract, Aloe leaf gel extract, glibenclamide. Liver tissues were examined histologically. The markers of oxidative stress: glutathione (GSH), non-enzymatic glycosylation (NEG) and lipid peroxidation (LPO), were determined in liver tissue. Biochemical parameters for liver function: serum alkaline phosphatase (ALP), and alanine transaminase (ALP) activities, were evaluated. All parameters were also determined in healthy (non diabetic) rats for comparison. In the diabetic control group, the degenerative changes in liver tissue were remarkable, while in the diabetic groups given Aloe pulp and gel extracts and glibenclamide, the damage to the liver tissue was decreased. The increase of GSH and the decrease of NEG and LPO in liver tissues with the treatment of Aloe gel extract, is consistent with the beneficial effect of Aloe. Serum ALP and ALT activities were also decreased in the groups given Aloe gel extract. It was concluded that Aloe gel extract has a protective effect comparable to glibenclamide against hepatotoxicity produced by diabetes if used in the treatment of type-II diabetes.
Diabetes is recognised as one of the leading causes of morbidity and mortality in the world. About 2.5-3% of the world's population suffers from this disease, a proportion which, in some countries, can reach 7% or more. Hyperglycemia leads to metabolic disorders and various complications. 1) There is increasing evidence indicating that enhanced production of free radicals may be an important contributing factor in the complications seen in diabetes. Species increased in diabetes, especially in uncontrolled diabetes, can lead to the autooxidation of glycosylated proteins, activation of the sorbitol pathway, induction of membrane damage, and oxidation of cellular lipids and proteins. 2) Many traditional plant treatments for diabetes mellitus are used throughout the world.
3) Management of diabetes without any side effects is still a challenge to the medical system. This leads to increasing demand for natural products with antidiabetic activity and fewer side effects. 4) Many herbs and plant products have been shown to have hypoglycemic action. 5) Aloe vera (L.) BURM. fil. (synonym A. barbadensis MILLER) (Liliaceae), native in North Africa, is one of these antidiabetic plants. Aloe species have been used for centuries for their various healing properties. 6) In the last decade there have also been reports on the antidiabetic activity of Aloe extracts. 7, 8) The Aloe plant contains anthraquinone glycosides, especially in the latex which is different from the gel, polysaccharides, aloeresins, glycomannans and b-sitosterol.
9,10) Antioxidative phenolic compounds were recently isolated from Aloe barbadensis and identified as aloeresin derivatives. 11, 12) In our previous studies we have reported the blood glucose lowering effect of Aloe vera leaf pulp and gel extracts on neonatal streptozotocin (n0STZ)-induced type-II diabetic rats in acute 13) and chronic 14) treatment. It is well known that STZ causes diabetes by the selective degeneration of pancreatic bcells. To date, research on traditional antidiabetic plants has been especially focused on STZ-induced type-I diabetic rats. It is assumed that herbal medicine can only be effective as an alternative to oral hypoglycemic agents, in type-II diabetes where pancreatic islets are not totally destroyed. That is why, n0STZ-induced type-II diabetic rats 15) were used in our investigation as well as glibenclamide, a known hypoglycemic agent, for comparison.
The present study was carried out to evaluate whether Aloe leaf pulp and gel extracts had any protective or harmful effect on the liver injury caused by type-II diabetes in n0STZ-induced diabetic rats.
MATERIALS AND METHODS

Plant Material
Specimens of Aloe vera (L.) BURM. fil. (in Turkish "Sarisabir") were collected from Kale (Demre) in Antalya, identified by N. Sütlüpinar (May 1993; a voucher specimen was deposited in the Herbarium of Istanbul University, Faculty of Pharmacy. ISTE No. 65118), planted and cultivated in the greenhouse of the Faculty of Pharmacy. Fresh leaves of this cultivated plant were used in this study.
Preparation of the Samples A. vera leaves (6 big leaves) were weighed, washed and cut in the middle, the gel was separated by scratching with a spoon.
Aloe vera Leaf Pulp Extract: The leaf pulp was cut into small pieces (514 g) and homogenized with phosphate buffered saline (PBS; pH 7; 600 ml) by means of a Moulinex Masterchief blender. The extract was kept at 4°C overnight, then filtered through cloth and the filtrate centrifuged at 20000 rpm for 30 min at 2°C in a refrigerated centrifuge (Cryofuge 20-3 Heraeus-Christ). The green pellet was discarded and the clear yellow supernatant was taken and lyophilized (Labconco apparatus). Thus, 29 g of A. vera leaf pulp extract was obtained. The extract used in the experiments (7.5%) was prepared by dissolving the powder in PBS and mixing it thoroughly via magnetic stirrer.
Aloe vera Leaf Gel Extract: The gel (400 gϭ2.5 g dry matter) was homogenized in a Waring blender, then diluted with an equal volume of PBS and homogenized for a second time. The extract was kept at 4°C overnight, then filtered through cloth. The clear filtrate was kept at Ϫ20°C in small portions.
Glibenclamide Suspension: Glibenclamide (5 mg) was suspended in 21 ml PBS; 4 ml propylene glycol was added and the mixture was kept in an ultrasonic water bath (47.6 kHz) for 45 min until a homogenous suspension was obtained.
Animals and Treatment. Type-II Diabetic Model Wistar pups were injected intraperitoneally on day 2 after birth with STZ (n0-STZ rats), 100 mg/kg, freshly dissolved in cold citrate buffer (1 mM, pH 4.5) according to Bonner-Weir et al. 15) This model of STZ-induced diabetes was reported by Portha et al. 16) as potentially appropriate for investigations in diabetes pharmacotherapy. The animals were controlled for the occurrence of diabetes after 6 weeks and the diabetics (fasting blood glucose levels 104-170 mg/dl; mean 137 mg/dl, also in accordance with type-II diabetic model) were taken for an experiment when they were 2 months old (90-120 g weight). Animals were allowed laboratory pellets and water ad libitum.
Animal Groups Group I: Healthy (non-diabetic; control) rats (5 animals) were kept under the same conditions as diabetic rats. Type-II diabetic rats were separated into 4 groups of 5-10 animals. Each group was given a sample as follows: Group II (untreated diabetic control): PBS (6 ml/kg), Group III: A. vera leaf pulp extract (500 mg/kg), Group IV: A. vera leaf gel extract (10 mlϭ63 mg/kg), Group V: Glibenclamide (1 mg/kg).
Administration of Samples Each group of animals was administered the above extracts orally each day for 15 d, by means of a catheter under mild ether anesthesia. The animals were sacrificed on the 15th day. Blood was taken by cardiac puncture, sera were separated for biochemical analysis. Liver tissues were taken for histological evaluation and biochemical assays.
Histological Evaluation The liver tissues taken from animals were fixed by Bouin's solution and embedded in paraffin after known routine procedures. Five micrometers thicksections were stained with hematoxylin-eosin (H-E) and Masson's tri-dye (Masson) and examined under a Carl Zeiss Ultraphot II microscope.
Biochemical Assays Livers were washed with saline and kept frozen until the day of the experiment, then homogenized in saline (1/10 w/v) by means of a Bandelin Sonopuls ultrasonic homogenizer (8 cycles/5 min). The homogenates were centrifuged in a Hereaus refrigerated centrifuge (4000 rpm/10 min) at 4°C and the clear supernatants were used for analysis. Liver tissue glutathione (GSH) was determined using Ellman's reagent. 17) In tissues non-enzymatic glycosylation (NEG) was evaluated by the 2-thiobarbituric acid method, 18) lipid peroxidation product (LPO) levels were measured as thiobarbituric acid related substances: TBARS by the method of Ledwozyw et al., 19) and protein by the Lowry method. 20) Serum alanine transaminase (ALT) activity was determined by the method of Reitman and Frankel, 21) and alkaline phosphatase (ALP) activity by the two point method.
22)
Statistical Analysis A computer program (SPSS, Science, Chicago, U.S.A.) was used for statistical analysis. Results were expressed as meansϮS.D. Variance analysis was used for comparison of the groups. Using a post hoc multiple comparison test, Dunnett's test was used to compare healthy controls and diabetic groups and Bonferroni's test to compare diabetic groups. A p value less than 0.05 was considered significant.
RESULTS
Histological Examination
The livers of healthy (non-diabetic) animals had a normal histological appearance (Fig.  1A) . In the hepatocytes of the diabetic control group, excess vacuolization and granular appearance in the cytoplasm in the periphery of the nucleus, picnotic nuclei, dilations in the sinusoids, the rupture in the central vein and moderate hyperemia were observed. An increase in the degeneration was observed from central veins to portal areas (Fig. 1B) . In the hepatocytes of the diabetic group given glibenclamide and Aloe extracts, in comparison to the diabetic control group however, it was noticed that the degenerative results were partly decreased in some animals and that the protective effect in tissues of these extract-administered diabetic groups was much greater than in the diabetic group given Aloe pulp, although there were individual differences (Figs. 1C-E) .
Biochemical Evaluation According to Table 1 , in liver tissues GSH levels did not change significantly in the PBS administered diabetic group compared to the healthy group. In contrast, these levels increased significantly with the treatment of Aloe pulp and gel extracts and glibenclamide in comparison to the diabetic control group (pϽ0.001 for all groups). In diabetic controls, NEG values were significantly increased in comparison to healthy rats [p (Dunnett's test)Ͻ0.001]. Compared to the diabetic control group, NEG values were decreased in groups given Aloe gel extract and glibenclamide (pϽ0.001) but increased in the group given Aloe pulp extract. LPO products were significantly increased in the diabetic group given PBS compared to the healthy group [p (Dunnet's test)Ͻ0.001]. Aloe pulp extract and glibenclamide significantly reduced LPO levels in comparison to diabetic controls (pՅ0.05) whereas the decrease with Aloe gel extract was found insignificant (Table 1) .
Serum ALP and ALT activities were significantly increased in type-II diabetic rats, compared to the healthy group [p (Dunnet's test)Ͻ0.001]. Serum ALP activity was significantly reduced in groups given Aloe gel and glibenclamide (pϽ0.05) but increased in the group given Aloe pulp in comparison to the diabetic control group. A significant decrease was found for ALT for the groups given Aloe leaf pulp and gel extracts (pϽ0.001), whereas glibenclamide did not effect ALT levels in comparison to the diabetic control group given PBS. (Table 2 ).
DISCUSSION
In recent years, various plant extracts have been claimed to be useful for the cure of diabetes mellitus [23] [24] [25] [26] but few of them were tested for their effects on tissues of diabetic animals. 23, 27, 28) Acute treatment with Aloe leaf pulp resulted in a 30% and 34% decrease in blood sugar levels of n0STZ-diabetic rats, after 2 and 3 h of administration of the extract respectively, 13) whereas chronic treatment with the same extract leads to 7% decrease in blood glucose on the 7th day of administration. 14) On the other hand, 11% and 14% reductions in blood glucose levels were observed 3 and 4 h after administration of Aloe leaf gel in acute studies 13) while only 3% and 9% decrease in blood sugar was seen in chronic studies on the 7th and 14th days, respectively, after oral administration of the gel extract 14) ; under the same conditions 14% and 13% reductions were observed with glibenclamide.
14) The present study was undertaken in order to examine morphologically and biochemically whether these Aloe extracts have a beneficial effect on liver tissue of type-II diabetic rats. Our histological findings (Fig. 1B ) are in agreement with the degenerative structural changes reported to occur in liver tissue as a result of insulin depletion. 29) The cytoprotective effect of Aloe extract against the cytotoxicity of 1,4-naphtoquinone in isolated rat hepatocytes was reported. 30) In the present study, the treatment with glibenclamide (Fig. 1C) and Aloe gel extract (Fig. 1D) reduced the degenerative changes, while Aloe pulp extract did not affect as glibenclamide or Aloe gel extract (Fig. 1E) .
It has been demonstrated that tissue antioxidant status is an important factor in the development of diabetic complications. 31) GSH plays an important role mainly in the detoxication and metabolism as a cofactor or a substrate for some enzymes and in this way is an antioxidant agent protecting tissues from oxidative stress and thus measured as a common marker of free radical damage. It is generally recognized that the detoxication function is impaired in diabetic animals. 32) Decrease in GSH levels demonstrates tissue damage. Indeed, it was demonstrated that lens 33) and liver 31, 32) GSH was lowered in diabetic rats. In the present study, the fact that liver GSH levels were insignificantly decreased in diabetic controls compared to healthy rats may be explained by the type of diabetes induced by neonatal STZ injection. In type II diabetes, pancreatic islets are not totally destroyed and minor insulin release still occurs. Blood glucose levels, previously reported in another study, 14) were in accordance with this type of diabetes. The increase in liver tissue GSH levels of diabetic rats given Aloe extracts as well as glibenclamide, in comparison to the diabetic control group (Table 1) , proves the beneficial effect of Aloe on tissue damage. Non-enzymatic glycosylation of proteins in tissues is correlated to the increase in blood glucose levels; in this way increase in NEG of liver proteins is also a well-known marker of diabetic damage. 34) In this study, the increase in liver tissue NEG levels provoked by diabetes was significantly lowered by Aloe gel and glibenclamide (Table 1 ). The increase in NEG observed by the treatment with Aloe pulp extract is in accordance with our previous study, 14) in which Aloe pulp extract increased blood glucose levels of n0-STZ diabetic rats on the 14th day of chronic treatment. This can also explain the increase produced by Aloe pulp extract in blood ALP.
Several studies have shown elevated levels of lipid peroxidation products in plasma of diabetic subjects 35) and rats. 36) Thiobarbituric acid related substances (TBARS) which are considered to be an index of endogenous lipid peroxidation, were found to be increased in liver after 4 weeks of diabetes.
37)
The liver damage caused by diabetes is probably due to lipid peroxidation subsequent to free radical production. The increase in liver tissue LPO product levels in the diabetic control group compared to healthy animals ( Table 1 ) is in agreement with the well-known fact that tissues of diabetic animals exhibit increased oxidative stress and disturbances in antioxidant defense compared to normal controls. 38, 39) This could be due to STZ treatment which generally induces oxidative predominance in tissues by generating nitrogen monoxide (NO). 40) Aloe leaf pulp extract as well as glibenclamide have a beneficial effect on liver by lowering LPO levels (Table 1 ). This antioxidant effect may be due to the aloeresin derivatives recently reported. 11, 12) Common biochemical markers of liver damage are the increase in activity of some enzymes like ALT and ALP in the blood. The injection of total glycoside of Aloe vera var. chinensis was found to be effective in lowering the elevated ALT in experimentally induced liver damage. 36) Aloe-emodin was also reported to have a protective effect on liver injury. 41) In another study, fresh leaf pulp extract of Aloe vera caused a decrease in malondialdehyde (MDA) formation in liver, suggesting the plant's role in the protection of oxidant induced cellular damage. 42) In the examination of the enzymes characteristic for liver function, in the diabetic groups given Aloe pulp and gel extracts a decrease in serum ALT, in contrast to an increase in the group given glibenclamide (Table 2) shows that Aloe extracts are more beneficial for liver than this latter known hypoglycemic drug. Though ALP is a marker for different metabolic functions, which could also have been impaired by diabetes, Aloe pulp extract could have decreased ALT which is a mainly hepatic enzyme, but increased ALP. The fact that the activity of ALP is increased by Aloe leaf pulp extract but decreased by Aloe gel extract, tend to propose the use of Aloe gel in preference to Aloe pulp extract (Table 2) .
It is concluded that, probably due to its antioxidant effects, Aloe leaf gel extract has a protective effect comparable to glibenclamide against hepatotoxicity produced by diabetes, and that Aloe gel could have a beneficial effect on liver if used as a hypoglycemic agent in the treatment of type-II diabetes. for providing and identifying the plant.
